
GLP-1 & PCOS: Why So Many Women Were Misdiagnosed
Episode 20
Linktree for Community Resources Need help appealing GLP-1 insurance denials? findhonestcare.com/kim Ro - Telehealth for GLP1 Weight Management Ro.Co/PlusSideZ _________________________________________________________________________ What if millions of women with PCOS were misunderstood for years because the condition was treated mainly as a reproductive disorder instead of a metabolic disease tied to insulin resistance, obesity, hormones, and fertility? In this episode of The Plus SideZ Podcast, Dr. Melanie Cree, a pediatric endocrinologist, obesity researcher, and PCOS/PMOS expert, explains the recent global consensus to rename PCOS to PMOS, or Polyendocrine Metabolic Ovarian Syndrome, to better reflect the condition’s metabolic and hormonal impact. Dr. Cree breaks down how delayed diagnosis and outdated understanding may have prevented many patients from getting earlier metabolic treatment and intervention. We discuss: Why so many women with PCOS were misunderstood or dismissed The connection between PCOS, PMOS, insulin resistance, obesity, and fertility Why weight gain is not just about willpower Adolescent PCOS and why early intervention matters GLP-1 medications like semaglutide for PCOS/PMOS Emerging research focused on ovulation, fertility, and metabolic health How hormones, appetite, and metabolism are connected Why the PMOS name change could improve diagnosis and treatment Dr.
Publisher
A GLP-1 Guide to Metabolic Health: The Plus SideZ Podcast
Published
May 23, 2026
Duration
1h 31m
Format
Podcast
Category
Lifestyle · Medicine
Source
RSS feed
Host
Kim Carlos
A GLP-1 Guide to Metabolic Health: The Plus SideZ Podcast
@aglp1guidetometabolichealtht
#pcos #manywomen #misdiagnosed #medicine #selfimprovement #nutrition
